Business
Rapid testing no substitute to COVID vaccination: Cochlear boss – Sydney Morning Herald
The $17 billion hearing implants maker has returned to profit, with its boss focused on emerging from the pandemic with a stronger…
The $17 billion hearing implants maker posted record sales of $1.4 billion for the 12 months to June and managed to spring from its $238 million loss in 2020 to a $327 million net profit for 2021.
The profit exceeded expectations, but overall sales came…
Continue Reading
-
Noosa News21 hours agoCrucial step in Sea World helicopter crash investigation set
-
General17 hours agoForget a tariff-induced recession, Australians have been in recession for two years
-
Business20 hours agoWhy Accent, DroneShield, EBR Systems, and Titomic shares are pushing higher
-
Business20 hours ago2 ASX 300 shares that look significantly undervalued